REGENXBIO Inc. (RGNX)

REGENXBIO Stock Forecast

Stock Price Forecast

The 8 analysts that cover REGENXBIO stock have a consensus rating of "Strong Buy" and an average price target of $28.75, which forecasts a 207.16% increase in the stock price over the next year. The lowest target is $12 and the highest is $50.

Price Target: $28.75 (+207.16%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$28.75	$30	$50
Change	+28.21%	+207.16%	+220.51%	+434.19%

* Price targets were last updated on Mar 9, 2026.

Analyst Ratings

The average analyst rating for REGENXBIO stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	3	3	3	3	3
Buy	3	4	4	4	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $32 → $30	Strong Buy	Maintains	$32 → $30	+220.51%	Mar 9, 2026
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Maintains $18 → $17	Buy	Maintains	$18 → $17	+81.62%	Mar 6, 2026
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $34 → $32	Strong Buy	Maintains	$34 → $32	+241.88%	Feb 10, 2026
Paul Choi Goldman Sachs	Goldman Sachs	Hold Maintains $14 → $12	Hold	Maintains	$14 → $12	+28.21%	Feb 10, 2026
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Maintains $25 → $18	Buy	Maintains	$25 → $18	+92.31%	Feb 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

255.92M

Increased by 50.15%

from 170.44M

Revenue Next Year

315.86M

Increased by 23.42%

from 255.92M

EPS This Year

-2.52

from -3.76

EPS Next Year

-2.87

from -2.52

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	470.35M	112.72M	90.24M	83.33M	170.44M	255.92M	315.86M
Revenue Growth	204.30%	-76.03%	-19.94%	-7.66%	104.54%	50.15%	23.42%
EPS	2.91	-6.50	-6.02	-4.59	-3.76	-2.52	-2.87
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	408.5M	563.3M
Avg	255.9M	315.9M
Low	132.3M	155.8M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	139.6%	120.1%
Avg	50.2%	23.4%
Low	-22.4%	-39.1%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	1.69	0.64
Avg	-2.52	-2.87
Low	-4.77	-6.21

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.